The novel approach of the medication represents a major advance in the handling of diabetes mellitus type 2. Different to existing medications, tirzepatide affects two pathways – the GLP-1 hormone and GIP – https://tirzepatide-peptide836021.blogdanica.com/42194384/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment